Christian Jan Fuchs

Christian Fuchs practices at Ascension Saint Thomas Hospital West in Nashville, Tennessee, part of Ascension Health Alliance.

Christian Fuchs' NPI, 1619243680, was assigned on March 23, 2012. Christian Fuchs graduated from Vanderbilt University School of Medicine in 2012. Christian Fuchs holds Tennessee license 56003.

Christian Fuchs' primary practice is Ascension Saint Thomas Hospital West, at 4220 Harding Rd, PO Box 380, Nashville, TN 37205 in Davidson County. The practice phone is (615) 222-2111.

Christian Fuchs' primary practice is Ascension Saint Thomas Hospital West in Nashville, Tennessee, part of Ascension Health Alliance. Christian Fuchs is also affiliated with Ascension Saint Thomas Three Rivers. The medical group on file is Ascension Saint Thomas Medical Partners. Dmand AI also links Christian Fuchs to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christian Fuchs practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Christian Fuchs' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Christian Fuchs is licensed in Tennessee.

CMS data shows 206 Medicare services from Christian Fuchs across 5 procedure codes in 2024, for 103 Medicare patients. Medicare paid $15,739 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 103 Medicare patients who saw Christian Fuchs in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christian Fuchs' median patient age at 62, with 53% women.

In 2024, Christian Fuchs wrote 1,846 Medicare Part D claims for 167 patients. 58% of them were for generic drugs. CMS names the drug for 1,405 of them, across 51 drugs with 11 or more claims each, at $2,060,761 in total drug cost. In 2023, CMS named 1,422 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Christian Fuchs for performance year 2024, reported as part of a group. Christian Fuchs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christian Fuchs as offering telehealth.

Dmand AI links 4 papers to Christian Fuchs, published from 2021 to 2024. 2024 was the busiest year, with 2. The most frequent topics are COVID-19, HIV Infections and SARS-CoV-2. Christian Fuchs' most frequent co-authors are Nathan Alan Summers, MD, Chinelo Ngozi Animalu, MD and Colten James Creel, MD.

CMS Open Payments shows 43 general payments to Christian Fuchs from 8 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $202.

Christian Fuchs graduated from Vanderbilt University School of Medicine in 2012.